The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
The size of the prize for earlier diagnosis of cancer in England
Open accessAbstract
BACKGROUND: This supplement presents a wide range of observations, reviews, novel research and analyses underpinning the National Awareness and Early Diagnosis Initiative (NAEDI). The preceding three papers present and discuss different aspects of the data from European cancer survival comparison studies. I conclude here by attempting to quantify the extent to which delayed diagnosis in England accounts for observed survival differences and by outlining areas for further research. METHODS: Analysis of indirect evidence related to late diagnosis, surgical intervention rates and utilisation of radiotherapy and chemotherapy in England and other European countries in the late 1990s for breast, colorectal and lung cancer. RESULTS: Late diagnosis was almost certainly a major contributor to poor survival in England for all three cancers. Low surgical intervention rates are very likely to have contributed to low survival rates for lung cancer and possibly for the other two cancers. Any differences in the use of radiotherapy or chemotherapy are likely to have had only a minor impact on survival differences. CONCLUSION: Between 5000 and 10000 deaths within 5 years of diagnosis could be avoided every year in England if efforts to promote earlier diagnosis and appropriate primary surgical treatment are successful. Detailed international benchmarking studies are to be recommended.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
(1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361402 · Cited by 2,517
What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable?
Abdel-Rahman, M., Stockton, D., Rachet, B., Hakulinen, T., & Coleman, M. P. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605401 · Cited by 160
Cited by
De Angelis, R., Sant, M., Coleman, M. P., Francisci, S., Baili, P., Pierannunzio, D., Trama, A., Visser, O., Brenner, H., Ardanaz, E., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70546-1 · Cited by 1,890
Parkin, D. M., Boyd, L., & Walker, L. C. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.489 · Cited by 663
Routes to diagnosis for cancer – determining the patient journey using multiple routine data sets
Elliss-Brookes, L., McPhail, S., Ives, A., Greenslade, M., Shelton, J., Hiom, S., & Richards, M. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.408 · Cited by 521
Self-citationQuaresma, M., Coleman, M. P., & Rachet, B. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61396-9 · Cited by 461
Cancer survival: global surveillance will stimulate health policy and improve equity
Coleman, M. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62225-4 · Cited by 370
Metadata
- Authors
- Richards, M. A.
- Venue
- British Journal of Cancer
- Published
- 2009-12
- Volume
- 101
- Issue
- S2
- Pages
- S125-S129
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- OpenAlex
- W2144416144
- Cited by
- 226
- References
- 2
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The size of the prize for earlier diagnosis of cancer in England. https://app.cochat.ai/papers/10.1038/sj.bjc.6605402
- The paper
- Richards, M. A. (2009). The size of the prize for earlier diagnosis of cancer in England. British Journal of Cancer. https://doi.org/10.1038/sj.bjc.6605402
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.